Hippocratic AI Raises $126 Million at $3.5 Billion Valuation in Series C
The company centers on non-diagnostic patient agents and a layered safety design.
Overview
- Avenir Growth led the financing, joined by CapitalG, General Catalyst, Andreessen Horowitz, Kleiner Perkins and health systems including Universal Health Services, Cincinnati Children’s and WellSpan Health.
- The raise brings Hippocratic AI’s total funding to $404 million.
- New capital is earmarked to expand customer deployments globally, advance the Polaris safety architecture and product innovation, and pursue mergers and acquisitions.
- Hippocratic AI builds patient-facing generative agents for tasks such as scheduling, intake, social determinants screenings, chronic care management and post-discharge outreach, and the agents do not diagnose or prescribe.
- The company reports partnerships with more than 50 healthcare organizations across six countries, including Cleveland Clinic, Northwestern Medicine, Moffitt Cancer Center, University Hospitals and Guy’s & St Thomas’ NHS Trust.